Experimental Biology and Medicine · 2009 · 13 citations · 23 references
Life SciencesBiochemistryPhysiologyCell SignalingMetabolic RegulationRenal PathophysiologyDiabetes MellitusDiabetic Kidney DiseaseDiabetic NephropathyGlomerular PathophysiologyInsulin Signaling In MetabolismRenal DiseaseAngiotensin Receptor SignalingDiabetes-related ComplicationsGlucose Homeostasis DisturbanceGlucose Transport RegulationGlut4 TranslocationMesangial Cell ActivationMesangial Cell Dysfunction
Mesangial cells (MCs) play a central role in the pathogenesis of diabetic nephropathy (DN). MC dysfunction arises from excessive glucose uptake through insulin-independent glucose transporter (GLUT1). The role of the insulin-dependent transporter (GLUT4) remains unknown. This study evaluated the effect of high glucose on GLUT1, GLUT4, and fibronectin expression levels. Glucose uptake was determined in the absence and presence of insulin. Angiotensin II has been implicated as a mediator of MC abnormalities in DN, and its effects on the GLUTs expression were evaluated in the presence of losartan. MCs were exposed to normal (NG, 10 mM) or high (HG, 30 mM) glucose for 1, 4, 12, 24, and 72 hrs. Glucose uptake was elevated from 1 hr up to 24 hrs of HG, but returned to NG levels after 72 hrs. HG induced an early (1-, 4-, and 12-hrs) rise in GLUT1 expression, returning to NG levels after 72 hrs, whereas GLUT4 was overexpressed at later timepoints (24 and 72 hrs). HG during 4 hrs induced a 40% rise in glucose uptake, which was unaffected by insulin. In contrast, after 72 hrs, glucose uptake was increased by 50%, only under insulin stimulus. Losartan blunted the effects of HG on GLUT1, GLUT4, and fibronectin expression and on glucose uptake. Results suggest that MCs can be highly susceptible to the HG environment since they uptake glucose in both an insulin-independent and insulin-dependent manner. The beneficial effects of angiotensin II inhibition in DN may also involve a decrease in the rate of glucose uptake by MCs.
23
Expression of transforming growth factor-β isoforms in human glomerular diseases
Tatsuo Yamamoto, Nancy A. Noble, Arthur H. Cohen et al. · Kidney International · 1996 · 420 citations
The Paradox of the Low-Renin State in Diabetic Nephropathy
Deborah A. Price, Lisa E. Porter, Michael Gordon et al. · Journal of the American Society of Nephrology · 1999 · 273 citations
Medicine, Endocrinology, Physiology +16
Daniela Berguio Vidotti, Dulce Elena Casarini, Priscila Cardoso Cristovam et al. · American Journal of Physiology-Renal Physiology · 2004 · 224 citations · Full text